GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) Director Richard C. Pfenniger, Jr. bought 5,000 shares of the company’s stock in a transaction dated Thursday, May 18th. The shares were acquired at an average cost of $5.90 per share, with a total value of $29,500.00. Following the acquisition, the director now directly owns 5,918 shares of […]
GeneDx (NASDAQ:WGS – Get Rating) and P3 Health Partners (NASDAQ:PIII – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Institutional and Insider Ownership 56.0% of GeneDx shares are […]
GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) shot up 3.5% during trading on Tuesday . The stock traded as high as $0.30 and last traded at $0.30. 2,943,442 shares were traded during mid-day trading, a decline of 25% from the average session volume of 3,940,957 shares. The stock had previously closed at $0.29. GeneDx Trading […]
GeneDx (NASDAQ:WGS – Get Rating) and Mitesco (OTCMKTS:MITI – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Risk & Volatility GeneDx has a beta of 1.91, suggesting that […]